TMCnet News

Online R&D and Business Tracker for Antibody-Drug Conjugates - Research and Markets
[September 19, 2016]

Online R&D and Business Tracker for Antibody-Drug Conjugates - Research and Markets


Research and Markets has announced the addition of the "R&D and Business Tracker for Antibody-Drug Conjugates" newsletter to their offering.

This information service about Antibody-Drug Conjugates (ADCs) delivers 12 monthly update reports in pdf format by e-mail straight to your desk and provides online access to the author's R&D database for the subject field of the service during the one-year subscription period. Credentials to access the online database will be sent by e-mail within 24 hours after purchase.

This product consists of:

  • 12 monthly update reports in pdf format delivered by e-mail;
  • online acces to ADC (News - Alert) R&D database during the 1-year subscription period.



The monthly update report about Antibody-Drug Conjugates contains:

  • R&D and Technology Tracker
  • Pipeline changes
  • Regulatory news
  • Technology validations

Business Tracker for:


  • Company updates
  • Collaboration
  • Licensing
  • Merger & acquisitions
  • Financing

Scope

  • Clinical Trial Tracker
  • Scientific Publication Tracker
  • Featured Cell Therapy Profile
  • Featured Company Profile
  • Featured Target (News - Alert) or Technology Pipeline

For more information about this newsletter visit http://www.researchandmarkets.com/research/l56l9n/randd_and

Related Topics: Oncology Drugs


[ Back To TMCnet.com's Homepage ]